
But it A new type of drug called dimethyl fumarate was recently approved in Europe as a basic treatment for multiple sclerosis. Various clinical studies have shown that it is effective in treating the symptoms of the said disease. But the underlying mode of action is not entirely known. But now, scientists from Bad Nauheim’s Max Planck